UNKNOWN

Bone Density of Newborn Infants to Mothers Treated With Selective Serotonin Reuptake Inhibitor (SSRI)

NCT00818727•Sheba Medical Center

Summary

SSRI treatment in adults was found to decrease bone density. The use of SSRI among pregnant women with depression or anxiety is extendent and raising. The effect of bone density of the infants was not yet evaluated.

Eligibility

Age

0 - 0 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Term newborn infants to mothers treated with SSRI and healthy controls

Exclusion Criteria

•Preterms, major congenital malformations.

Key Dates

Start Date

February 1, 2009

Primary Completion Date

January 1, 2011

Last Updated

January 8, 2009

Enrollment

40

ESTIMATED participants

Conditions

Bone Density

Role of Estrogen on Skeletal Outcomes in FHA

NCT07010146

Bone StrengthBone Density+1 more

View study

RECRUITINGEARLY_PHASE1

Topic Simvastatin for Bone Regeneration

NCT07031778

Dimensional ChangesBone Density

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 8, 2009Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

RECRUITINGNA